Profil
Christopher C.
Feistel was associated with the company nRichDX, Inc. where he held the position of Chief Technology Officer from 2005 to 2017.
He is also the founder of nRichDX, Inc. which was founded in 2005.
Ehemalige bekannte Positionen von Christopher C. Feistel
| Unternehmen | Position | Ende |
|---|---|---|
nRichDX, Inc.
 nRichDX, Inc. Medical DistributorsDistribution Services nRichDX, Inc. develops vitro diagnostic products and solutions. It provides the sensitive targeted cell enrichment solution for the cancer patients. The firm’s products are EpiSeP, paramagnetic anti bodies, conjugate antibodies and stains, laboratory reagents, specimen debulking and mixing tools. The company was founded by Chris Feistel and Robert L. Coleman on January 20, 2005 and is headquartered in Irvine, CA. | Gründer | 01.07.2017 |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
nRichDX, Inc.
nRichDX, Inc. Medical DistributorsDistribution Services nRichDX, Inc. develops vitro diagnostic products and solutions. It provides the sensitive targeted cell enrichment solution for the cancer patients. The firm’s products are EpiSeP, paramagnetic anti bodies, conjugate antibodies and stains, laboratory reagents, specimen debulking and mixing tools. The company was founded by Chris Feistel and Robert L. Coleman on January 20, 2005 and is headquartered in Irvine, CA. | Distribution Services |
